This fully GMP-compliant perfusion bioreactor is engineered for high-cell-density continuous mammalian cell culture, ideal for high-titer mAbs, recombinant proteins, viral vectors and advanced biotherapeutics commercial manufacturing.
Constructed with electropolished 316L stainless steel wetted surfaces and seamless orbital welding, the unit supports automated CIP and SIP cycles and passes full E&L testing, fully meeting global cGMP, FDA and EMA regulatory standards. Integrated in-situ cell retention module continuously retains viable cells inside the bioreactor while continuously harvesting clarified supernatant, realizing long-term uninterrupted perfusion cultivation. Closed-loop automatic regulation of DO, pH, temperature, agitation and overlay gas delivers stable homogeneous culture microenvironment, sustaining ultra-high viable cell density and drastically elevating volumetric productivity compared with conventional fed-batch processes.
The automation system complies with ISA-88 batch control architecture, supporting customizable perfusion feeding strategies, real-time flux adjustment, automatic backflushing and fouling protection. Complete electronic batch records and immutable audit trails are generated automatically to satisfy data integrity requirements for regulatory submission and on-site inspections.
With scalable geometric design and consistent kLa mass transfer coefficients, process parameters can be reliably transferred from pilot scale to large commercial scale without rework. It effectively reduces bioreactor footprint, cuts medium consumption and lowers downstream processing load, perfectly fitting dedicated high-yield continuous biomanufacturing workshops and flexible multi-product GMP production facilities.
